TOKYO — Shares of Japanese household goods maker Kao rose on Thursday after the company said it has jointly developed an antibody that suppresses new coronavirus infections.
The VHH antibody developed by the partnership is derived from camelids that are one-tenth the size of conventional antibodies and less costly to produce.
Kao, along with researchers at Kitasato University and Japanese biotech startup Epsilon Molecular Engineering, said they hope the findings will lead to the development of drugs for treating coronavirus infections.
The maker drew on experience with culturing microorganisms for detergents. In the joint study, Kao used technology from the